Life Science Forum @ 2013 Chinese New Year Gala

February 10, 2013


1:30PM – 2:00PM Registration
2:00PM – 2:02PM Opening
Xiangyang Yu, Ph.D., Forum Chair
2:02PM – 2:04PM Welcome Address

Philip Zhang, Ph.D., J.D., President, CABA

2:04PM – 3:35PM Recent Trends in Bio-Pharma Industry

Introduction by: Yihan Wang, Ph.D., forum co-chair

Steven Projan, Ph.D. SVP of R&D and Innovative Medicines Head for Infectious Diseases & Vaccines at MedImmune

“Who will mourn the passing of the pharmaceutical industry”

Suvit Thaisrivongs, Ph.D. Head of Immunoscience Chemistry, Pfizer, Inc.

“Xeljanz: now FDA approved for Rheumatoid Arthritis”

Tomi Sawyer, Ph.D. CSO, SVP of Discovery & Innovative Tech., Aileron Therapeutics, Inc.

“Stapled Peptide Drugs: Transforming Nature’s alpha-Helix into Breakthrough Medicines”

3:35PM – 3:45PM Coffee Break

3:45PM – 4:45PM Panel: Investment in BioPharma and Legal Considerations

Moderator: Charlotte Kim, Partner, Wilson Sonsini Goodrich & Rosati, P.C.

Charlotte Kim, Partner, Wilson Sonsini Goodrich & Rosati, P.C.

“Financing Biopharma Companies: Opportunities and Managing Risks”

Jasemine C. Chambers, Ph.D., Of Counsel, Wilson Sonsini Goodrich & Rosati, P.C.

“IP Strategy - Getting Ready For Funding Pitch And Beyond”

George Dai, Ph.D., Deputy Chief Investment Officer & Head of Alternative Investment, Weatherbie & Co., Inc.

“Emptying Cage and Changing the Bird—Outlook of China”

John Hession, Partner, Cooley LLP

“Launching the Start Up”

Henry Gu, Counsel, WilmerHale LLP

“How Entrepreneurs Can Thrive Under the ‘First-to-File’ Patent System”

4:45PM – 5:30PM Panel: Options and Opinions on Career Development

Moderator: Xiang Y. Yu, Ph. D. Principal Investigator, Ironwood Pharmaceuticals

Jie Zheng, President/CEO, China Association for International Exchange of Personnel New York, Ltd.

Hao Li, Ph.D., Head, Site Cambridge of Novartis Knowledge Center, Novartis Institute of BioMedical Research

Kevin Fang, Ph.D., Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals

Wei Zhang, Ph.D. Director of Commercial Strategies, Harvard Stem Cell Institute

Philip Zhang, Ph. D., J. D. Co-Founder and Co-Managing Principal, Milstein Zhang & Wu LLC

5:30PM Closing Remarks

Shiwen Lin, Ph.D., Chair, CABA Board of Directors

5:30PM – 6:30PM Cocktail Reception/Social Networking

The admission to the afternoon life science forum is Free

Tickets for Gala dinner: Early Bird ticket: $60.00 before Jan 31, 2013; Regular ticket: $75.00 after Jan 31, 2013; Student ticket: $40.00, limited quantity of discounted ticket available for current student.

Buy Ticket Online(For CABA member, please contact Dr. Ze Tian: